Alliance Trust PLC Reports Latest Net Asset Values for Shares
![Alliance Trust PLC Reports Latest Net Asset Values for Shares](https://investorshangout.com/images/blog/ihnews-Alliance%20Trust%20PLC%20Reports%20Latest%20Net%20Asset%20Values%20for%20Shares.jpg)
Understanding Alliance Trust PLC's Latest NAV Updates
ALLIANCE TRUST PLC
At the close of business recently, significant updates regarding the Company’s net asset value (NAV) per ordinary share were announced. This information is crucial for investors looking to evaluate their positions accurately.
Latest NAV Figures
The NAV per ordinary share, calculated on a bid price basis while considering debt at par, revealed the following:
- Excluding income: 1226.0p
- Including income: 1225.3p
Furthermore, when assessed with debt at fair value, the figures were as follows:
- Excluding income: 1228.8p
- Including income: 1228.1p
Contact Information for Further Inquiries
For individuals seeking more details regarding these valuations, you can reach out to:
Juniper Partners Limited
Telephone: +44 (0)131 378 0500
The Importance of Accurate NAV Calculations
Understanding a company’s net asset values is vital for potential and current investors. These calculations adhere strictly to published accounting policies and the Association of Investment Companies (AIC) guidelines, ensuring transparency and reliability.
The fair value of fixed loan notes held by the Company is evaluated based on a benchmark gilt, further clarifying the financial positioning of Alliance Trust PLC in the market.
Key Dividend Information
It is also important to note that the upcoming dividend of 6.62p, scheduled for payment, will have been deducted from the 'including income' figures mentioned above as of the ex-dividend date, which was established as 29 August 2024.
Implications for Investors
For investors, these NAV figures are more than just numbers—they represent a guiding light in terms of making informed decisions about buying, holding, or selling shares in Alliance Trust PLC. The information helps in assessing both the current performance and future potential of the trust.
Frequently Asked Questions
What is the significance of NAV in investing?
NAV, or Net Asset Value, reflects the per-share value of a fund or company, essential for investors evaluating market positions.
Who can provide more information on Alliance Trust PLC?
Further details can be obtained by contacting Juniper Partners Limited directly.
How are NAV figures calculated?
NAVs are calculated following specific accounting policies and AIC guidelines, ensuring reliability and transparency.
What does 'including income' mean in this context?
'Including income' refers to the NAV figures that account for expected income from dividends or other sources, providing a true reflection of the share's worth.
When is the next dividend payment scheduled?
The next dividend payment of 6.62p is set to be paid on 27 September, 2024, post the ex-dividend date.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- KeyCorp Strategically Repositions Portfolio for Growth
- Analysts Project Strong Growth Potential for Broadcom Stock
- Exploring the Future of Magnetoresistive RAM Technology Growth
- Land Survey Equipment Market Poised for Remarkable Growth by 2028
- HII Launches REMUS 620 UUVs, Transforming Ocean Research Today
- Forrester's Insights on AI Strategies for Tech Leadership in 2025
- Exciting Launch of Madden NFL Youth Championship for Students
- Trump's Proposal for IVF Coverage: A New Era for Families
- ON2IT Enhances Cybersecurity Landscape with Zero Trust 2.0
- Caravelle International Group Reports Fiscal Year 2023 Loss
Recent Articles
- Discovering Promising Financial Stocks for Investment Growth
- Surge in Trump Media Stocks: Impacts and Future Outlook
- Allied Gold Launches Trading on OTCQX Best Market Today
- SelectQuote Plans Earnings Release for Fiscal Year 2024 Insights
- Strategic Move: G Mining Ventures Completes Project Acquisition
- Simply Better Brands Corp. Expands TRUBAR™ Distribution Nationwide
- GR Silver Mining Plans $1.76 Million Private Placement Funding
- Methanex Acquires OCI's Methanol Business in Strategic $2.05B Deal
- Rethinking Strategies: How Creators Can Shine This Election
- Recognize Expands Portfolio with Blue Mantis Majority Investment
- First Citizens Bank Facilitates Major Financing for Swift Current
- Allied Gold Begins Trading on OTCQX Market for Growth
- Palatin Technologies Outlines Key Clinical Program Milestones
- 5 Accounting Software Tools Every Small Investor Needs to Know About
- G Mining Ventures Secures CentroGold Project for Future Growth
- Somite Therapeutics Partners with OmniaBio for Cell Therapy
- Viasat Plans Major Offering of Senior Secured Notes
- Discover the Revolutionary Protein Candy™: The Super Candy!
- Nvidia's Gross Margin Outlook: Strategic Moves Ahead
- Understanding Dividend Investing for Sustainable Wealth Growth
- The Impact of Wealth Taxes on High Net Worth Individuals
- Evolving Trends in the Laundry Detergent Market for 2034
- Exploring Insights from the Latest Half-Year Report 2024
- Vyne Dental Achieves Recognition in Digital Health Awards 2024
- Shifts in International Education Preferences Among Generations
- Squarespace and Permira Revise Merger Agreement for Enhanced Value
- Natural Grocers and Bitchin' Sauce Team Up for a Cause
- MercadoLibre's Ambitious Growth Plans in Latin America's Market
- Autonomix Sees Significant Pain Reduction in Clinical Trial
- Nova Vision Acquisition Corp. Expands Trust Account for Business Deal
- Aurora Cannabis and Vectura Launch Innovative Luo CBD Lozenge
- Quant Fund Market Expected to Grow to $38.90 Billion
- Maximizing Your Investment: Dividend Income from AT&T
- Zentalis Pharmaceuticals Unveils Promising Azenosertib Findings
- Coinbase Global: A Smart Growth Investment for Your Portfolio
- Financial Insights and Progress for 2024 from Australian Oilseeds
- Coppernico Metals Advances Drilling and Conference Engagements
- Market Recovery on the Horizon as Investors Anticipate Fed Moves
- Solaris Resources Advances Warintza Project with EIA Submission
- Major Drilling Reports Successful Annual Shareholder Meeting Results
- Apogee Therapeutics Welcomes Jeff S. Hartness as Chief CCO
- Akero Therapeutics Commences Patient Dosing in Key Study
- Tilray Medical's Breakthrough in Fibromyalgia Pain Relief
- Canoo's Exciting Relocation and Growth in Oklahoma and Texas
- Evaxion's Innovative mRNA Gonorrhea Vaccine Shows Promise
- Regeneron's Exciting Advancements in Cancer Treatment Showcase
- Moody's Upgrades Phillips Edison to Baa2 Rating with Stability
- Mobilicom's Financial Surge: An Insight into Growth and Strategy
- Terns Pharmaceuticals Reports Successful Phase 1 Trial with TERN-601
- OraSure Technologies Welcomes Jack Kenny to Board Leadership